Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of antiprotozoal and antimicrobial agents. Its nitroimidazole core contributes to biological activity against anaerobic pathogens. Commonly employed in research settings to design new drug candidates targeting parasitic infections such as giardiasis and trichomoniasis. Also utilized in the preparation of functionalized imidazole derivatives for medicinal chemistry and biological screening.